Former Pakistani President General Pervez Musharraf has expressed his will to get medical treatment of his choice in another country, citing the findings of his medical report which shows serious illness.
The report prepared by the Armed Forces Institute of Cardiology (AFIC) warned that it can be quickly life-threatening in the event of destabilisation, particularly under stress or during a coronary intervention, the Express Tribune reports.
Meanwhile, the doctors said that a coronary angiogram is required urgently to ascertain the need for more medical procedures.
However, public prosecutor Akram Sheikh requested the court not to announce its decision on the report, expressing serious reservations over the findings, and suggested that an independent medical board comprising the country's top five cardiologists should be asked to file a separate report.
The court has adjourned the hearing till January 29, the report added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
